Document is current
Any future updates will be listed below
-
Authors
Port, Helena
Coppers, Birte
Tragl, Sonja
Manger, Eva
Niemiec, Lisa M.
Bayat, Sara
Simon, David
Fagni, Filippo
Corte, Giulia
Bay-Jensen, Anne-Christine
Tascilar, Koray
Hueber, Axel J.
Schmidt, Katja G.
Schönau, Verena
Sticherling, Michael
Heinrich, Simon
Leyendecker, Sigrid
Bohr, Daniela
Schett, Georg
Kleyer, Arnd
Holm Nielsen, Signe
Liphardt, Anna-Maria
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 11 April 2025
First Online: 21 April 2025
Declarations
:
: Signe Holm Nielsen and Anne-Christine Bay-Jensen: Employed and owner of stocks at Nordic Bioscience A/S, Anna-Maria Liphardt: Grant/research support from Novartis Pharma GmbH, Germany. All further listed authors declare no conflict of interest concerning this study.
: The study protocols were approved by the Friedrich-Alexander-Universität Erlangen-Nürnberg ethics committee (study 1 and 2: #125_16B; study 3: #357_20B) and participants were included after giving written informed consent. All methods were performed in accordance with the Declaration of Helsinki.
